<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
	<TITLE>$titleTag</TITLE>
<STYLE type="text/css">
   subtoolbar {border-top-width: 0px; border-top-style: none;}


   
 </STYLE>	
</head>
<body>
	
	<table width="940" height="496" border="0" align="center" cellpadding="0" cellspacing="0">
		<tr>
			<td height="489" align="right" valign="top"><SPAN><BR><INPUT type="BUTTON" name="BUTTON" value="< BACK" onclick="javascript: history.go(-1)" /></SPAN><BR>
			<table width="100%">
				<tr valign="top" align="left" style="color:#0066FF">
					<th width="33%">j100274</th>
					<th width="33%">i25750568</th>
					<th width="33%"><A HREF='http://phoenix.jstor.org/Phoenix/toc/secure/issue.html?workType=mod&journalId=10.2307/j100274&issueId=10.2307_i25750568' target='_blank'>PHX Link</A></th>
				</tr>
			</table>
			<P align='left' style='color:#993300'><B><u>10.2307/25750575</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Concerns about the use of mastectomy and breast reconstruction for breast cancer have motivated interest in surgeon's influence on the variation in receipt of these procedures.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Concerns about the use of mastectomy and breast reconstruction for breast cancer have motivated interest in surgeon's influence on the variation in receipt of these procedures.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Objectives: To evaluate the influence of surgeons on variations in the receipt of mastectomy and breast reconstruction for patients recently diagnosed with breast cancer.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Methods: Attending surgeons (n = 419) of a population-based sample of breast cancer patients diagnosed in Detroit and Los Angeles during June 2005 to February 2007 (n = 2290) were surveyed. Respondent surgeons (n = 291) and patients (n = 1780) were linked. Random-effects models examined the amount of variation due to surgeon for surgical treatment. Covariates included patient clinical and demographic factors and surgeon demographics, breast cancer specialization, patient management process measures, and attitudes about treatment.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Results: Surgeons explained a modest amount of the variation in receipt of mastectomy (4%) after controlling for patient clinical and sociodemographic factors but a greater amount for reconstruction (16%). Variation in treatment rates across surgeons for a common patient case was much wider for reconstruction (median, 29%; 5th—95th percentile, 9%–65%) then for mastectomy (median, 18%; 5th—95th percentile, 8% and 35%). Surgeon factors did not explain between-surgeon variation in receipt of treatment. For reconstruction, 1 surgeon factor (tendency to discuss treatment plans with a plastic surgeon prior to surgery) explained a substantial amount of the between-surgeon variation (31%).</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>5</TD><TD width='5%' bordercolor='blue'>Conclusion: Surgeons have largely adopted a consistent approach to the initial surgery options. By contrast, the wider between-surgeon variation in receipt of breast reconstruction suggests more variation in how these decisions are made in clinical practice.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25750576</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Colorectal cancer (CRC) screening is recommended for all adults 50 to 75 years old, yet only slightly more than one-half of eligible people are current with screening. Because CRC screening is usually initiated upon recommendations of primary care physicians, interventions in these settings are needed to improve screening.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Colorectal cancer (CRC) screening is recommended for all adults 50 to 75 years old, yet only slightly more than one-half of eligible people are current with screening. Because CRC screening is usually initiated upon recommendations of primary care physicians, interventions in these settings are needed to improve screening.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Objectives: To assess the impact of a quality improvement intervention combining electronic medical record based audit and feedback, practice site visits for academic detailing and participatory planning, and "best-practice" dissemination on CRC screening in primary care practice.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Research Design: Two-year group randomized trial.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Subjects: Physicians, midlevel providers, and clinical staff members in 32 primary care practices in 19 States caring for 68,150 patients 50 years of age or older.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>5</TD><TD width='5%' bordercolor='blue'>Measures: Proportion of active patients up-to-date (UTD) with CRC screening (colonoscopy within 10 years, sigmoidoscopy within 5 years, or at home fecal occult blood testing within 1 year) and having screening recommended within past year among those not UTD.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>6</TD><TD width='5%' bordercolor='blue'>Results: Patients 50 to 75 years in intervention practices exhibited significantly greater improvement (from 60.7% to 71.2%) in being UTD with CRC screening than patients in control practices (from 57.7% to 62.8%), the adjusted difference being 4.9% (95% confidence interval, 3.8%–6.1%). Recommendations for screening also increased more in intervention practices with the adjusted difference being 7.9% (95% confidence interval, 6.3%–9.5%). There was wide interpractice variation in CRC screening throughout the intervention.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>7</TD><TD width='5%' bordercolor='blue'>Conclusions: A multicomponent quality improvement intervention in practices that use electronic medical record can improve CRC screening.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25750577</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Transplant center performance evaluations have garnered substantial attention in recent years. Among sources of bias that may affect measured performance are underlying characteristics of donor organs. An unresolved question is whether centers accepting higher-risk donations are placed in jeopardy for lower evaluations independent of actual quality of care.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Transplant center performance evaluations have garnered substantial attention in recent years. Among sources of bias that may affect measured performance are underlying characteristics of donor organs. An unresolved question is whether centers accepting higher-risk donations are placed in jeopardy for lower evaluations independent of actual quality of care.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Objective: The primary aim was to assess whether unmeasured characteristics of donor organs impact risk-adjusted outcomes used for center performance evaluations.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Subjects: The study included adult kidney transplant recipients (n = 53,791) from 1994 to 2008 from a national registry.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Research Design: We compared adjusted graft survival with use of paired-donor kidneys (allocated to high- and low-performing centers) and unpaired donor kidneys to investigate whether measured center performance was consistent with organs derived from the same donor (minimizing the influence of noncodified risk factors).</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>5</TD><TD width='5%' bordercolor='blue'>Results: The primary finding was that differences between centers were unaffected by use of paired or unpaired donations (hazard ratio for patients transplanted at high performing centers with paired kidneys = 0.63 [95% CI, 0.53–0.74] and with unpaired kidneys = 0.66 [95% CI, 0.62–0.70], P value for interaction = 0.52). This finding was consistent over 5 consecutive cohorts, based on either concurrent or prospective outcomes and by altering the threshold criteria for identification of performance outliers.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>6</TD><TD width='5%' bordercolor='blue'>Conclusions: Results indicate that underlying selection bias from donor characteristics does not impact transplant center evaluations. This is important evidence that donor selection is not a primary driver for evaluated quality of care among transplant centers and acceptance of higher-risk kidneys should not be perceived as a primary threat to measured performance.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25750578</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Black prostate cancer patients are less likely to receive aggressive therapy (AT) than Whites: reported rates for patients ?65 years old are about 55% versus 65%. Little is known about treatment rates in socioeconomically deprived states with large Black populations like Alabama.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Black prostate cancer patients are less likely to receive aggressive therapy (AT) than Whites: reported rates for patients ?65 years old are about 55% versus 65%. Little is known about treatment rates in socioeconomically deprived states with large Black populations like Alabama.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Study Design: Medicare claims and Alabama Statewide Cancer Registry records were linked for Alabamian men in Medicare fee-for-service diagnosed with loco-regional prostate cancer in 2000–2002. The association between race and likelihood of: (1) AT (prostatectomy or external beam radiation therapy [EBRT] or brachytherapy); (2) hormone therapy (primary androgen deprivation therapy [ADT] or orchiectomy); (3) <30 days of EBRT; and (4) <6 months of ADT, was investigated adjusting for age, clinical tumor stage, grade, Comorbidity Index, and census tract proportion of Black residents, of persons living below poverty and with ? high school.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: Of 3561 patients, 71.2% received AT and 38.3% hormone therapy. Blacks were less likely to receive AT (64.3% vs. 73.0%, adjusted [adj.] OR: 0.80, CI: 0.67–0.96). There was no difference between Blacks and Whites in the likelihood of receiving hormone therapy (40.8% vs. 37.7%, adj. OR: 1.10, CI: 0.91–1.34), <30 days of EBRT (30.5% vs. 31.5%, adj. OR: 0.98, CI: 0.72–1.32) or <6 months of ADT (50.7% vs. 54.0%, adj. OR: 0.84, CI: 0.63–1.12).</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: In Alabama, there were racial differences in utilization of aggressive treatment for locoregional prostate cancer. Research should investigate factors associated with prostate cancer treatment among older men, such as patient behavior and access to care.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25750571</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Unit costs of health services are substantially higher in the United States than in any other developed country in the world, without a correspondingly healthier population. An alternative payment structure, especially for high volume, high cost episodes of care (eg, total knee replacement), is needed to reward high quality care and reduce costs.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Unit costs of health services are substantially higher in the United States than in any other developed country in the world, without a correspondingly healthier population. An alternative payment structure, especially for high volume, high cost episodes of care (eg, total knee replacement), is needed to reward high quality care and reduce costs.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Methods: The National Inpatient Sample of administrative claims data was used to measure risk-adjusted mortality, postoperative length-of-stay, costs of routine care, adverse outcome rates, and excess costs of adverse outcomes for total knee replacements performed between 2002 and 2005. Empirically identified inefficient and ineffective hospitals were then removed to create a reference group of high-performance hospitals. Predictive models for outcomes and costs were recalibrated to the reference hospitals and used to compute risk-adjusted outcomes and costs for all hospitals. Per case predicted costs were computed and compared with observed costs.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: Of the 688 hospitals with acceptable data, 62 failed to meet effectiveness criteria and 210 were identified as inefficient. The remaining 416 high-performance hospitals had 13.4% fewer risk-adjusted adverse outcomes (4.56%–3.95%; P < 0.001; ?²) and 9.9% lower risk-adjusted total costs ($12,773–$11,512; P < 0.001; t test) than all study hospitals. Inefficiency accounted for 96% of excess costs.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusions: A payment system based on the demonstrated performance of effective, efficient hospitals can produce sizable cost savings without jeopardizing quality. In this study, 96% of total excess hospital costs resulted from higher routine costs at inefficient hospitals, whereas only 4% was associated with ineffective care.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25750572</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Nursing Home Compare first published clinical quality measures at the end of 2002. It is a quality report card that for the first time offers consumers easily accessible information about the clinical quality of nursing homes. It led to changes in consumers' demand, increasing the relative importance of clinical versus hotel aspects of quality in their search and choice of a nursing home.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Nursing Home Compare first published clinical quality measures at the end of 2002. It is a quality report card that for the first time offers consumers easily accessible information about the clinical quality of nursing homes. It led to changes in consumers' demand, increasing the relative importance of clinical versus hotel aspects of quality in their search and choice of a nursing home.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Objectives: To examine the hypothesis that nursing homes responding to these changes in demand shifted the balance of resources from hotel to clinical activities.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Subjects: The study included 10,022 free-standing nursing homes nationwide during 2001 to 2006.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Research Design and Data: A retrospective multivariate statistical analysis of trends in the ratio of clinical to hotel expenditures, using Medicare cost reports, Minimum Data Set and Online Survey, Certification and Reporting data, controlling for changes in residents' acuity and facility fixed effects. Inference is based on robust standard errors.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>5</TD><TD width='5%' bordercolor='blue'>Results: The ratio of clinical to hotel expenditures averaged 1.78. It increased significantly (P < 0.001) by 5% following the publication of the report card. The increase was larger and more significant among nursing homes with worse reported quality, lower occupancy, those located in more competitive markets, for-profit ownership and owned by a chain.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>6</TD><TD width='5%' bordercolor='blue'>Conclusions: The increase in the ratio of clinical to hotel expenditures following publication of the report card suggests that nursing homes responded as expected to the changes in the elasticity of demand with respect to clinical quality brought about by the public reporting of clinical quality measures. The response was stronger among nursing homes facing stronger incentives.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25750573</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: The individual contributions of behavior problems to key and related outcomes in dementia, such as nursing home admission (NHA) or caregiver burden, remain unclear.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: The individual contributions of behavior problems to key and related outcomes in dementia, such as nursing home admission (NHA) or caregiver burden, remain unclear.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Objectives: This study sought to determine the ramifications of temporal change in individual behavior problems when accounting for increases in caregiver burden and time to NHA. Although burden is sometimes conceptualized as an antecedent to NHA, it has also emerged as a relevant outcome in dementia caregiving research.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Methods: A sample of 4545 dementia caregivers who participated in the Medicare Alzheimer disease. Demonstration Evaluation was selected for this secondary analysis. Various patterns of change in individual behavior problems were considered as predictors of increases in caregiver burden and time to NHA over a 3-year period via mixed effects and Cox proportional hazards models, respectively.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Results: Caregivers who did not indicate a care recipient's dangerous behavior initially but did so subsequently (ie, an "incident" behavior problem) were more likely to experience increases in burden (P < 0.0026). Alternatively, the persistent occurrence of behavior disturbances (particularly memory problems) emerged as the strongest predictors of time to NHA.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>5</TD><TD width='5%' bordercolor='blue'>Discussion: The findings of this study suggest the benefit of examining temporal patterns of individual behavioral disturbances, and that incident and persistent problems account for different dementia outcomes over time. Considering the temporal ramifications and potency of specific behavior problems can facilitate the targeted and timely delivery of effective clinical interventions.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25750574</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Objective: To investigate the lifelong health effects, costs, and cost-effectiveness of a quality improvement collaborative focusing on improving diabetes management in an integrated care setting.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Objective: To investigate the lifelong health effects, costs, and cost-effectiveness of a quality improvement collaborative focusing on improving diabetes management in an integrated care setting.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Study Design and Methods: Economic evaluation from a healthcare perspective with lifetime horizon alongside a nonrandomized, controlled, before-after study in the Netherlands. Analyses were based on 1861 diabetes patients in 6 intervention and 9 control regions, representing 37 general practices and 13 out-patient clinics. Change in the United Kingdom Prospective Diabetes Study score, remaining lifetime, and costs per quality-adjusted life year gained were calculated. Probabilistic life tables were constructed using the United Kingdom Prospective Diabetes Study risk engine, a validated diabetes model, and nonparametric bootstrapping of individual patient data.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Results: Annual United Kingdom Prospective Diabetes Study risk scores reduced for cardiovascular events (hazard ratio: 0.83 and 0.98) and cardiovascular mortality (hazard ratio: 0.78 and 0.88) for men and women, respectively. Life expectancy improved by 0.97 and 0.76 years for men and women, and quality-adjusted life years by 0.44 and 0.37, respectively. Higher life expectancy in the intervention group increased lifelong costs by €860 for men and €645 for women. Initial program costs were about €22 per patient. The incremental costs per quality-adjusted life year were €1937 for men and €1751 for women compared with usual care costs. There is a probability >95% that the collaborative is cost-effective, using a threshold of €20,000 per quality-adjusted life year.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Conclusion: Optimizing integrated and patient-centered diabetes care through a quality-improvement collaborative is cost-effective compared with usual care.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25750580</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Research regarding the association between mental health and colorectal cancer (CRC) screening has produced mixed results. Variations may be explained by methodology, including whether potential confounders such as frequency of healthcare visits are considered.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: Research regarding the association between mental health and colorectal cancer (CRC) screening has produced mixed results. Variations may be explained by methodology, including whether potential confounders such as frequency of healthcare visits are considered.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Objective: We examined the association between mental health and CRC screening, before and after controlling for demographics, comorbidities, and outpatient visit frequency.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Design: Observational study based on a retrospective cohort.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Subjects: A total of 855 veterans receiving care at a Veterans Affairs Medical Center.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>5</TD><TD width='5%' bordercolor='blue'>Measures: Medical record data were used to assess CRC screening rates and mental health status (number of diagnoses and the presence of depression, anxiety, posttraumatic stress disorder, substance, or psychotic disorders). Logistic regression was used to estimate the association between mental health diagnoses and CRC screening, before and after controlling for covariates.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>6</TD><TD width='5%' bordercolor='blue'>Results: Bivariate analyses suggested that CRC screening rates were higher for patients with a history of one or more mental health diagnoses (57% vs. 47%, P < 0.01). However, adjusting for timing of mental health diagnosis and outpatient visit frequency resulted in significant negative associations between CRC screening and all measures of mental health except posttraumatic stress disorder.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>7</TD><TD width='5%' bordercolor='blue'>Conclusions: Estimates of the association between mental health and CRC screening that do not adjust for outpatient visit frequency may be misleading. Veterans with mental health diagnoses were significantly less likely to be screened for CRC than their counterparts with no mental health diagnoses and an equal number of outpatient visits.</TD></TR></table><P align='left' style='color:#993300'><B><u>10.2307/25750579</u></B></P><BR><P align='left' style='color:#CC66FF'><B><u>Current Issuemap</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: One approach postulated to improve the provision of health care is effective utilization of team-based care including pharmacists.</TD></TR></table><P align='left' style='color:#FF9900'><B><u>Most Eligible Issuemap Info</u></B></P><BR><table width='100%'><TR valign='top'><TD width='5%' bordercolor='blue'>1</TD><TD width='5%' bordercolor='blue'>Background: One approach postulated to improve the provision of health care is effective utilization of team-based care including pharmacists.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>2</TD><TD width='5%' bordercolor='blue'>Objective: The objective of this study was to conduct a comprehensive systematic review with focused meta-analyses to examine the effects of pharmacist-provided direct patient care on therapeutic, safety, and humanistic outcomes.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>3</TD><TD width='5%' bordercolor='blue'>Methods: The following databases were searched from inception to January 2009: NLM PubMed; Ovid/MEDLINE; ABI/INFORM; Health Business Fulltext Elite; Academic Search Complete; International Pharmaceutical Abstracts; PsycINFO; Cochrane Database of Systematic Reviews; National Guideline Clearinghouse; Database of Abstracts of Reviews of Effects; ClinicalTrials.gov; LexisNexis Academic Universe; and Google Scholar. Studies selected included those reporting pharmacist-provided care, comparison groups, and patient-related outcomes. Of these, 56,573 citations were considered. Data were extracted by multidisciplinary study review teams. Variables examined included study characteristics, pharmacists' interventions/services, patient characteristics, and study outcomes. Data for meta-analyses were extracted from randomized controlled trials meeting meta-analysis criteria.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>4</TD><TD width='5%' bordercolor='blue'>Results: A total of 298 studies were included. Favorable results were found in therapeutic and safety outcomes, and meta-analyses conducted for hemoglobin A1c, LDL cholesterol, blood pressure, and adverse drug events were significant (P < 0.05), favoring pharmacists' direct patient care over comparative services. Results for humanistic outcomes were favorable with variability. Medication adherence, patient knowledge, and quality of life-general health meta-analyses were significant (P < 0.05), favoring pharmacists' direct patient care.</TD></TR><TR valign='top'><TD width='5%' bordercolor='blue'>5</TD><TD width='5%' bordercolor='blue'>Conclusions: Pharmacist-provided direct patient care has favorable effects across various patient outcomes, health care settings, and disease states. Incorporating pharmacists as health care team members in direct patient care is a viable solution to help improve US health care.</TD></TR></table>
				
		</td>
		</tr>
	</table>		
</body>
</html>
